AmberGen, based in Boston, MA, is a cutting-edge company specializing in transforming spatial biology through the innovative use of mass spectrometry technology. Their Miralys Imaging system allows for the analysis of small and large molecules in the same sample, enabling the co-registration of therapeutic and target data to achieve new levels of multiplexity.
With a focus on multiplex multiomic multimodal whole slide imaging, AmberGen has announced a strategic partnership with Bruker to further advance their capabilities in spatial biology research. Their technology offers the ability to analyze up to 100 biomarkers in a single scan, making them a leader in the field of targeted spatial biology imaging.
Generated from the website